Sun Pharma Advanced Research Company Ltd will hold a board meeting on Monday, November 02, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, according to a regulatory filing with the National Stock Exchange of India Ltd and BSE Limited. The trading window for company shares has been closed for directors, key managerial personnel, designated employees, and connected persons from October 01, 2026, and will remain closed until 48 hours after the financial results are declared and submitted to the stock exchanges.